Skip to main content
. 2017 May 19;2017(5):CD011598. doi: 10.1002/14651858.CD011598.pub2

Valdivieso 1987.

Methods Randomised clinical trial, USA
Participants 65 hospitalised adults, previously untreated, with small cell bronchogenic carcinoma admitted for chemotherapy, at nutritional risk according to the trialist
Male:Female = 40:18
Mean age = 59 years
Interventions Experimental group: Intravenous hyperalimentation 500 ml 50% glucose, 500 ml 8.5% amino acid(n = 30)
 Control group: No intervention (n = 35)
Co‐intervention: oral nutrition as wanted + chemotherapy
Outcomes Myelosuppresive toxicity, infectious complications, weight, triceps skinfold, mid‐upper arm muscle circumference, days of hospitalisation, survival, remission
Study dates Not stated
Notes The same participants were randomised to prophylactic antibiotics or no prophylactic antibiotics. The 2 groups of antibiotics could be described as being similar in the 2 groups. We contacted the authors on 23rd June 2015 by email: manuelva@umich.edu. The author replied that he had left the research environment and could not provide further information.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not described
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk Not described
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Not described
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk There were above 5% dropouts, and the trial did not use proper methodology to deal with those lost to follow‐up.
Selective reporting (reporting bias) Low risk The trial reported mortality and serious adverse events.
For‐profit bias Low risk The trial was funded by a non‐profit organisation (National Cancer Institute).
Other bias Low risk The trial appeared to be free of other components that could put it at risk of bias.